Vimarsana
Biggest News Aggregation in the World

Page 2 - Decision Score News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Decision Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Decision Score Today - Breaking & Trending Today

PreludeDx™ to Present New DCISionRT® Comparative Data in - Vimarsana News

PreludeDx™ to Present New DCISionRT® Comparative Data in

Data to Address Limitations in the Applications of Clinicopathologic Factors ...

Strong Analytical Validation Data Further Supports Use of DCISionRT® to Guide Shared Decision-Making for DCIS Therapeutic Management - Vimarsana News

Strong Analytical Validation Data Further Supports Use of DCISionRT® to Guide Shared Decision-Making for DCIS Therapeutic Management

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced that...

PreludeDx Presents Comparative Data Analyzing Racial/Ethnic Radiation Therapy Treatment Recommendation Changes using DCISionRT - Vimarsana News

PreludeDx Presents Comparative Data Analyzing Racial/Ethnic Radiation Therapy Treatment Recommendation Changes using DCISionRT

Results show Black women had significantly higher rates of radiation therapy recommendation compared to White women with similar biosignature scores 

DCISionRT® by PreludeDx™ Receives Advanced Diagnostic Laboratory Test (ADLT) Status Approval from the Centers for Medicare & Medicaid Services - Vimarsana News

DCISionRT® by PreludeDx™ Receives Advanced Diagnostic Laboratory Test (ADLT) Status Approval from the Centers for Medicare & Medicaid Services

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced that...

PreludeDx™ Presents New Data at the 40th Annual Miami Breast Cancer Conference Identifying Which Patients with DCIS May Be Undertreated Based on Clinicopathologic Factors Alone - Vimarsana News

PreludeDx™ Presents New Data at the 40th Annual Miami Breast Cancer Conference Identifying Which Patients with DCIS May Be Undertreated Based on Clinicopathologic Factors Alone

/PRNewswire/ -- Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, today announced it...